Logo image
Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports
Journal article   Open access

Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports

Vithor de Oliveira Carvalho, Francisco Leonardo Galastri, Breno Boueri Affonso, Priscila Mina Falsarella, Leonardo Guedes Moreira Valle, Ben-Hur Ferraz-Neto, Marcelo Bruno de Rezende, Joaquim Maurício da Motta-Leal-Filho, Rodrigo Gobbo Garcia and Felipe Nasser
Einstein (São Paulo, Brazil), Vol.18, p.eRC4990
01/01/2020
DOI: 10.31744/einstein_journal/2020RC4990
PMID: 32130329
url
https://doi.org/10.31744/einstein_journal/2020RC4990View
Published (Version of record) Open Access

Abstract

Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially considered unresectable have been enframed as candidates for curative therapy after hepatic transarterial radioembolization. We report three cases in which the hepatic transarterial radioembolization was used as neoadjuvant therapy in an effective way, allowing posterior potentially curative therapies.
Adult Aged Bile Duct Neoplasms - therapy Carcinoma, Hepatocellular - therapy Chemoembolization, Therapeutic - methods Cholangiocarcinoma - therapy Disease Progression Female Humans Liver Neoplasms - therapy Male Middle Aged Neoadjuvant Therapy - methods Treatment Outcome Yttrium Radioisotopes

Details

Metrics

Logo image